Flushing: FDA reporting patterns
100,760 FDA FAERS reports mention Flushing. 37,788 reports have a serious outcome flag.
Medicines named as suspect
- Niacin: 22,590 reports
- Dimethyl Fumarate: 16,854 reports
- Simvastatin: 5,392 reports
- Treprostinil: 3,507 reports
- Infliximab: 3,132 reports
- Paclitaxel: 1,957 reports
- Ambrisentan: 1,863 reports
- Dalfampridine: 1,676 reports
- Diroximel: 1,599 reports
- Glatiramer: 1,511 reports
- Epoprostenol: 1,413 reports
- Rituximab: 1,204 reports
FAERS reports describe events reported after a medicine was taken. They do not prove that the medicine caused an event, measure how often a side effect occurs, or estimate personal risk.
Source: FDA FAERS via openFDA. FAERS data through 2026-06-30. Sources, methods, and limitations.